|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitor Phentermine, Quan Urine
Test Code13113
Preferred Specimen
Reject Criteria:
Preserved samples
PREFERRED
3 mL random urine collected in a clinical drug test vial,
room temperature
Minimum: 2 mL
--or--
ACCEPTABLE
3 mL random urine collected in a leakproof, urine
container, room temperature
Minimum: 2 mL
RT: 14 days
Refrigerated (cold packs): 14 days
Frozen: 30 days
Preserved samples
PREFERRED
3 mL random urine collected in a clinical drug test vial,
room temperature
Minimum: 2 mL
--or--
ACCEPTABLE
3 mL random urine collected in a leakproof, urine
container, room temperature
Minimum: 2 mL
RT: 14 days
Refrigerated (cold packs): 14 days
Frozen: 30 days
Minimum Volume
2 mL
Other Acceptable Specimens
3 mL Urine (Min2 mL)
Urine Container, leak-proof (Random); Room Temperature;
Urine Container, leak-proof (Random); Room Temperature;
Transport Container
Clinical drug test transport vial
Transport Temperature
Room Temperature
Specimen Stability
Room Temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
Mass Spectrometry
Setup Schedule
Monday-Sunday Evening
Report available: 3 Days
Report available: 3 Days
Reference Range
See Laboratory Report
Clinical Significance
Phentermine is a prescription stimulant. Because taking
phentermine comes with a risk of dependence, it is
considered a controlled substance. It's chemically
similar to the stimulant amphetamine, which is also a
controlled substance. The test is a definitive assay
using liquid chromatography mass spectroscopy (LC/MS/MS)
methodology. Therapeutic urine drug monitoring of
phentermine is important for ensuring compliance to
treatment strategies, as well as ensuring non-diversion
for illicit purposes. Urine or oral fluid are the
specimens of choice for routine monitoring of patients
taking prescription drugs. Use of serum/plasma should be
limited to anuretic patients, or where a patient's
clinical appearance does not coincide
with their prescribed medications. No single monitoring
approach provides adequate information about the pattern
or dose of
patient drug use. Safest prescribing habits should
include a combination of tools and laboratory test
results to correctly detect drug use patterns.
Quantitative values cannot be used to assess the drug
dose, because the drug is extensively metabolized and
excreted in the urine.
phentermine comes with a risk of dependence, it is
considered a controlled substance. It's chemically
similar to the stimulant amphetamine, which is also a
controlled substance. The test is a definitive assay
using liquid chromatography mass spectroscopy (LC/MS/MS)
methodology. Therapeutic urine drug monitoring of
phentermine is important for ensuring compliance to
treatment strategies, as well as ensuring non-diversion
for illicit purposes. Urine or oral fluid are the
specimens of choice for routine monitoring of patients
taking prescription drugs. Use of serum/plasma should be
limited to anuretic patients, or where a patient's
clinical appearance does not coincide
with their prescribed medications. No single monitoring
approach provides adequate information about the pattern
or dose of
patient drug use. Safest prescribing habits should
include a combination of tools and laboratory test
results to correctly detect drug use patterns.
Quantitative values cannot be used to assess the drug
dose, because the drug is extensively metabolized and
excreted in the urine.
